Price movement over the last 24 hours
ARK Genomic Revolution ETF vs Innovative Industrial Properties Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Innovative Industrial Properties Inc trades at $64.44 (market cap $1.87B). The key difference: Innovative Industrial Properties Inc pays a 11.79% dividend while ARK Genomic Revolution ETF pays none, and Innovative Industrial Properties Inc is trading nearer its 52-week high, ARK Genomic Revolution ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | IIPR | |
|---|---|---|
Sector | Sector/Thematic | Real Estate |
52-Week High | $43.57 | $64.44 |
52-Week Low | $23.09 | $44.58 |
Market Cap | — | $1.87B |
Enterprise Value | — | $2.25B |
Dividend Yield | — | 11.79% |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
IIPR trades at $64.44, up 2.16% with a bullish technical signal from moving averages. The REIT shows strong profitability with 45.58% net margins and stable quarterly earnings beats. Recent developments include successful debt refinancing and a $1.90 quarterly dividend declaration. Valuation appears reasonable with P/E of 16.44 and P/B of 1.05, though revenue declined to $266M in 2025.
Outlook remains positive with cannabis rescheduling progress and improved capital structure, but risks include tenant credit quality and sector volatility. The 13.32% dividend yield offers income appeal, though coverage requires monitoring. Analyst consensus leans cautious with 36% buy ratings amid revenue pressure.
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.
Read more on IIPR →